AUTHOR=Tong Xiaoxia , Qu Xiaofei , Wang Mengyun 

TITLE=A Four-Gene-Based Prognostic Model Predicts Overall Survival in Patients With Cutaneous Melanoma

JOURNAL=Frontiers in Oncology

VOLUME=11

YEAR=2021

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.639874

DOI=10.3389/fonc.2021.639874

ISSN=2234-943X

ABSTRACT=<sec><title>Background</title><p>Cutaneous melanoma (CM) is one of the most aggressive cancers with highly metastatic ability. To make things worse, there are limited effective therapies to treat advanced CM. Our study aimed to investigate new biomarkers for CM prognosis and establish a novel risk score system in CM.</p></sec><sec><title>Methods</title><p>Gene expression data of CM from Gene Expression Omnibus (GEO) datasets were downloaded and analyzed to identify differentially expressed genes (DEGs). The overlapped DEGs were then verified for prognosis analysis by univariate and multivariate COX regression in The Cancer Genome Atlas (TCGA) datasets. Based on the gene signature of multiple survival associated DEGs, a risk score model was established, and its prognostic and predictive role was estimated through Kaplan-Meier (K-M) analysis and log-rank test. Furthermore, the correlations between prognosis related genes expression and immune infiltrates were analyzed <italic>via</italic> Tumor Immune Estimation Resource (TIMER) site.</p></sec><sec><title>Results</title><p>A total of 103 DEGs were obtained based on GEO cohorts, and four genes were verified in TCGA datasets. Subsequently, four genes (<italic>ADAMDEC1, GNLY, HSPA13</italic>, and <italic>TRIM29</italic>) model was developed by univariate and multivariate Cox regression analyses. The K-M plots showed that the high-risk group was associated with shortened survival than that in the low-risk group (<italic>P</italic> &lt; 0.0001). Multivariate analysis suggested that the model was an independent prognostic factor (high-risk vs. low-risk, HR= 2.06, <italic>P</italic> &lt; 0.001). Meanwhile, the high-risk group was prone to have larger breslow depth (<italic>P</italic>&lt; 0.001) and ulceration (<italic>P</italic>&lt; 0.001).</p></sec><sec><title>Conclusions</title><p>The four-gene risk score model functions well in predicting the prognosis and treatment response in CM and will be useful for guiding therapeutic strategies for CM patients. Additional clinical trials are needed to verify our findings.</p></sec>